The healthcare sector is constantly evolving to meet the needs of consumers and adapt to technological advancements.
DexCom, a company in the medical device industry, has faced recent challenges but remains well-positioned for long-term success in continuous glucose monitoring (CGM) systems. The global penetration of CGM technology is low, indicating significant growth potential. DexCom is actively expanding into new markets and has introduced Stelo, an over-the-counter CGM option. Its leadership in the CGM sector has created a network effect that enhances patient care and positions the company for sustained growth.
DexCom's future prospects in CGM systems are promising, making it an attractive investment option.
Intuitive Surgical, another prominent player in the medical device industry, specializes in robotic-assisted surgery (RAS) with its da Vinci surgical system. This system offers numerous benefits, including reduced recovery times and minimized scarring. Intuitive Surgical's focus on continuous improvement and technological advancement ensures its position at the forefront of the surgical landscape. The company also invests in training programs for surgeons and healthcare professionals, solidifying its reputation as a trusted partner.
Investors should consider the unique advantages that DexCom and Intuitive Surgical offer in the healthcare sector. DexCom's expansion in CGM offerings and Intuitive Surgical's enhancement of robotic surgery capabilities present opportunities for market-beating returns.